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Background: Urinary tract infections (UTIs) are a very most common type of infection
worldwide, and result in billions of dollars in medical care costs. Escherichia coli is
the infective agent for 80–90% of all UTIs. Green tea, derived from leaves of the
Camellia sinensis plant has been shown to have various potential health beneﬁts (e.g.,
cardiovascular disease and cancer). The major beneﬁcial components of green tea have
, been characterized, and are now known to be polyphenolic catechins. The main catechins
in green tea are (−)-epicatechin-3-gallate, (−)-epigallocatechin (EGC), (−)-epicatechin, and
(−)-epigallocatechin-3-gallate (EGCG). EGCG and EGC have been shown to have the great-
est antimicrobial effects, but only EGC has been shown to be excreted in urine. Isolates of
E. coli from UTIs collected between 2007 and 2008 were characterized for antimicrobial
resistance to standard drugs. Then 80 of these isolates, representing a wide spectrum
of antimicrobial susceptibility patterns, were selected for testing using an extract of
green tea.
Results:The concentrations of green tea extract testedwere 0, 2.5, 3.0, 3.5, and 4.0mg/ml.
All of the strains tested, except one, had minimum inhibitory concentrations (MICs) of
≤4.0 mg/ml (99%), with 94% of the isolates having an MIC of ≤3.5 mg/ml, 76% of the
isolates having an MIC of ≤3.0 mg/ml, 40% of the isolates having an MIC of ≤2.5 mg/ml.
Two control strains varied in susceptibility, one having an MIC of ≤2.5 mg/ml,and the other
having an MIC of ≤3.5 mg/ml.
Conclusion: Since EGC has been shown to have antimicrobial effects on E. coli, and EGC
has been shown to be excreted in the urine in a high enough concentration to potentially
be effective as an antimicrobial; these MIC results suggest that ingesting green tea could
have potential antimicrobial effects on UTIs caused by E. coli.
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INTRODUCTION
Urinary tract infections (UTIs) are the second most common type
of infection found in anyorgan system, and themost common type
of nosocomial infection (Carson and Naber, 2004). These UTIs
are responsible for over eight million doctors visits per year in the
U.S. (National Institute of Diabetes and Digestive and Kidney Dis-
eases, 2005), and result in medical costs of over six billion dollars
worldwide per year (Anderson et al., 2004b; Kucheria et al., 2005).
Most UTIs (80–90%) are the result of infections with Escherichia
coli (Karlowsky et al., 2002). Non-pathogenic strains of E. coli are
an important part of the normal ﬂora in the human intestinal
tract.
The strains of E. coli that infect the urinary tract are categorized
as uropathogenic E. coli (UPEC; Kaper et al., 2004). The UPEC are
able to produce special surface proteins (adhesins) that allow them
to attach to and invade the epithelial cells that line the urinary
bladder (Anderson et al., 2004a; Schaeffer et al., 2004; Kau et al.,
2005; Marrs et al., 2005). If the infection is not eradicated while it
is in the bladder (uncomplicated UTI), some strains of UPEC may
then travel up the ureters to the kidneys and cause evenmore severe
infections (complicatedUTIs),which can lead to renal damage and
possibly renal failure (Kaper et al., 2004; Pichon et al., 2009). There
are 14 serogroupsof UPEC that aremost commonly found inUTIs,
and 75% of UTIs have been shown to be caused by serogroups 04,
06, 014, 022, 075, and 083 (Stenutz et al., 2006; Li et al., 2010).
The most common serogroups involved in causing UTIs world-
wide are 02, 04, 06, and 075 (George and Manges, 2010). In the
U.S., 49% of UTIs in women have been found to be caused by
serogroups 06, 04, and 075, in descending frequency of occurrence
(Vosti, 2007).
The antimicrobial agents that have traditionally been used
to treat UTIs (β-lactams, ﬂuoroquinolones, trimethoprim–
sulfamethoxazole, nitrofurantoin, etc.) are becoming less effective
(Warren et al., 1999; Wagenlehner and Naber, 2005). In recent
years, the number of antimicrobial resistant strains of E. coli
isolated from UTIs has been increasing, including resistance
to antimicrobial agents normally used to treat UTIs (Sahm
et al., 2001; Kahlmeter, 2003; Muratani and Matsumoto, 2004;
Landgren et al., 2005; Zhanel et al., 2006). Even though sci-
entists are constantly working to develop new and improved
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antimicrobials, almost as soon as a new drug is released, the
bacteria show resistance to it. These isolates are also showing resis-
tance to drug combinations such as amoxicillin/clavulanic acid,
piperacillin/tazobactam, and trimethoprim/sulfamethoxazole
(Dias et al., 2009; Gündog˘du et al., 2011; Jadhav et al., 2011;
Molina-López et al., 2011; Oliveira et al., 2011).
Green tea is derived from non-fermented leaves of the Camel-
lia sinensis plant. Oolong and black tea are made from fermented
leaves of the same plant. Green tea has been a favored drink,
traditionally, in Asian countries. Because of studies that have
shown the potential health beneﬁts of green tea, it is now
gaining worldwide popularity as a drink that is important in
preventative medicine. Studies using green tea have shown it
to have potential beneﬁts, most notably in: cardiovascular dis-
ease, cancer, diabetes, obesity, oral health, bone health, and
cognitive function (McKay and Blumberg, 2002; Cabrera et al.,
2006; Chacko et al., 2010; Mak, 2012). In addition, green
tea has been shown to have antimicrobial effects (Yam et al.,
1997; Taylor et al., 2005; Friedman, 2007; Song and Seong,
2007).
The components in green tea that are responsible for these
various effects are polyphenols (also known as catechins). The
main catechins in green tea are (−)-epicatechin (EC), (−)-
epicatechin-3-gallate (ECG), (−)-epigallocatechin (EGC), and
(−)-epigallocatechin-3-gallate (EGCG), which have been shown
to make up approximately 30–40% of the water-soluble solids in
brewed green tea (Wang and Ho, 2009). Three of these catechins,
ECG, EGC, and EGCG have been show to have antimicrobial
effects against a wide variety of microorganisms (Yam et al.,
1997; Taguri et al., 2004, 2006; Taylor et al., 2005; Friedman,
2007; Song and Seong, 2007). The two found in the high-
est amounts in green tea are EGC and EGCG. Both of these
are excreted in bile, but EGC is also excreted in the urine,
suggesting the possibility for green tea having antimicrobial activ-
ity in UTIs (Yang et al., 1998; Lee et al., 2002; Cabrera et al.,
2006; Luo et al., 2006). Most of the studies on how these com-
pounds accomplish the antibacterial activity have focused on
EGCG. Because EGCG is not excreted in the urine (Yang et al.,
1998), it is not the compound of interest for this study. One
study has found that EGC is able to bind to the ATP bind-
ing site of the bacterial gyrase B subunit, thus inhibiting gyrase
activity (Gradišar et al., 2007). The aim of the current study
was to investigate the susceptibility of UPEC strains, represent-
ing a wide variety of antimicrobial susceptibility patterns, to
green tea.
MATERIALS AND METHODS
BACTERIA STRAINS
The bacterial strains used in this study were part of a research
collection of E. coli isolated from UTI cultures during the
years of 2007–2008. There were 80 isolates selected from this
collection that represented a wide spectrum of antimicrobial sus-
ceptibility patterns; in addition, two control strains that were
susceptible to all the clinically tested (prior to this study) antimi-
crobials were selected. Table 1 shows the antimicrobial agents
tested and frequency of the strains that were resistance to each
drug.
Table 1 | Frequency of the antimicrobial resistance of E. coli strains
used in this study.
Antimicrobial Resistant, n (%)
Ampicillin 63 (78)
Piperacillin 57 (71)
Ampicillin/sulbactam 53 (66)
Tetracycline 35 (44)
Ciproﬂoxacin 33 (41)
Trimethoprim/sulfamethoxazole 29 (36)
Cefazolin 12 (15)
Gentamicin 12 (15)
Tobramycin 10 (13)
Cefuroxime 9 (11)
Amoxicillin/clavulanic acid 7 (9)
Aztreonam 5 (6)
Ceftriaxone 5 (6)
Nitrofurantoin 5 (6)
Cefepime 4 (5)
Norﬂoxacin 3 (4)
Piperacillin/tazobactam 2 (3)
GREEN TEA EXTRACT
Astandardized green tea (C. sinensis) extract (standardized to 7.0%
polyphenols) was obtained from Swanson Vitamins. The plant
extract was prepared in water.
MEDIA
Themedia used in these experimentswas Luria-Bertani (LB) broth
(Teknova brand), and dehydrated Müller-Hinton agar (MHA; BD
brand).
MINIMUM INHIBITORY CONCENTRATION DETERMINATION
The minimum inhibitory concentration (MIC) of the green tea
extract was determined by agar dilution method. MHA plates
that contained various concentrations of green tea extract (0,
2.5, 3.0, 3.5, and 4.0 mg/ml) were prepared. Suspensions of 0.5
McFarland standard dilutions (equal to 1.5 × 108 cells/ml) were
prepared from bacterial cultures grown overnight in LB broth.
A 10−4 dilution of these suspensions was prepared, and 100 μl
of dilution per plate was inoculated using a spread plate tech-
nique (plated concentration equals 1.5 × 103 cells). Inoculated
plates were incubated at 37◦ C for 48 h, and on the basis of
colony counts, the MIC was determined as the lowest concen-
tration of green tea extract to show an inhibitory effect on growth
of the bacteria (no colonies detected). Each strain was tested three
times.
RESULTS
MIC DETERMINATION
The MICs and susceptibility results are as follows: 99% were sus-
ceptible to the green tea extract at a concentration of ≤4.0 mg/ml
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Table 2 | Minimum inhibitory concentrations for total green tea
extract (GTE) and the EGC component.
Component Number of isolates tested (% out of 79)
32 (40%) 29 (37%) 14 (18%) 4 (5%)
Total GTE (mg/ml) ≤2.5 ≤3.0 ≤3.5 ≤4.0
EGC (μg/ml) ≤450 ≤540 ≤630 ≤720
(one strain was not susceptible at even 4.0 mg/ml); 94% were
susceptible at ≤3.5 mg/ml; 76% were susceptible at ≤3.0 mg/ml;
40%, were susceptible at ≤2.5 mg/ml; The control strains varied;
one being susceptible at ≤2.5 mg/ml and the other susceptible at
≤3.5 mg/ml. Table 2 shows the MIC results for the 79 strains that
were susceptible at ≤4.0 mg/ml.
DISCUSSION
The green tea extract was shown to have an inhibitory effect on
the growth of E. coli strains isolated from UTIs. The MIC results
can be adjusted to reﬂect the EGC content, using a value of 18%
EGC as the content in total green tea polyphenols (Vuong et al.,
2011). That makes the adjusted results as follows: 40% of strains
tested were susceptible at a concentration of EGC at ≤0.45 mg/ml
(450 μg/ml); 36% susceptible at ≤0.54 mg/ml (540 μg/ml); 18%
susceptible at ≤0.63 mg/ml (630 μg/ml); and 5% susceptible at
≤0.72 mg/ml (720 μg/ml). Since all of the strains tested (99%)
were susceptible at a concentration of ≤0.72 mg/ml, this suggests
that EGC might be a good inhibitor of bacterial growth. Table 2
shows the MIC data for total green tea extract and for the EGC
component.
The data was collected by in vitro experiments, but the effect
can be described using information that is known about the
metabolism of EGC from green tea. The amount of green tea
polyphenols that would be present in the urine, including the
amount of EGC, will vary according to the origin of the tea. It has
been found, for instance, that Japanese tea (an average of 15 teas)
contains approximately 20 mg of EGC per gram of dry tea (Vuong
et al., 2011). An average cup of Japanese green tea is made with one
tablespoon of dry tea (instructions from package of tea) which is
equivalent to approximately 7.5 g of dry tea (a package of 60 g of
dry tea makes eight cups). That equates to approximately 150 mg
of EGC per cup of Japanese green tea.
Urinary excretion after a single ingested dose of EGC has been
shown to peak at 8 h after ingestion, with levels in the urine reach-
ing to 3.0–5.0 mg (Yang et al., 1998). The amount of EGC excreted
after ingestion of one cup of tea (as described above) should equal
approximately 3.5 mg. Since the projected MICs for EGC are well
below 3.5 mg, this suggests that even one cup of green tea could
have an effect on a urinary tract pathogen, and drinking multiple
cups over the course of a day could possibly provide a prolonged
effect. Additional studies testing the in vivo effect of drinking green
tea on UTIs could be useful for determining if the effects observed
in this study have medical signiﬁcance.
Studies have shown that concentrations of 500 μg of tea
polyphenols can inhibit the growth of E. coli, and that concen-
trations of ≥5000 μg are considered bactericidal. This effect is
believed to be due to the fact that tea polyphenols down regulate
the production of proteins such as EF-2 (elongation factor for pro-
tein translation); proteins involved in phospholipid, carbon, and
energy metabolism; and production of proteins involved in amino
acid biosynthesis (Cho et al., 2007).
There was no correlation between MIC values in this study
and the antimicrobial resistance of the isolates. Each level of MIC
contained a variety of antimicrobial resistance patterns.
Another set of studies that would be interesting and poten-
tially useful would be to test EGC and several of the standard
antimicrobial agents used to treat UTIs to determine if there
might be synergism between EGC and any of the antimicrobial
agents. Studies have been done that show the ability of green tea
to act synergistically with gentamicin and amikacin against E. coli
(Neyestani et al., 2007).
CONCLUSION
The results of this study have shown that green tea can have an
antimicrobial effect on E. coli bacteria that cause UTIs. This is the
ﬁrst time that green tea has been reported to have this kind of
effect. The data also adds to the current information on the poten-
tial health beneﬁts of green tea. It is our hope that these ﬁndings
will encourage further studies on the antimicrobial potential of
green tea and other plant components.
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